Researchers at Bar-Ilan University have discovered that changing just one letter in DNA can completely alter sex development ...

The ability of different genetic variants—changes to one or more building blocks of DNA—to cause disease, and to what extent, ...

University of Virginia School of Medicine scientists have used a next-generation form of gene editing to fix the underlying cause of a severe form of epilepsy in lab mice.

Missense mutations have been extensively studied in tumor-suppressing antigens (TP53) to understand oncogenesis within malignant epithelial cells. Using Whole Exome Sequencing (WXS), missense ...

Mechanical harvesting is replacing labor-intensive hand-plucking to meet global tea production needs. However, many traditional tea cultivars have soft, droopy leaves that break easily during machine ...

Olomorasib combined with Keytruda targets KRAS G12C-mutant NSCLC, receiving FDA Breakthrough Therapy designation for its promising efficacy in early trials. The designation is based on LOXO-RAS-20001 ...

Prime editing (PE) enables precise genome modification, i.e., all 12 types of base substitution, as well as designed insertion and deletion. Previously, we developed an efficient PE system using a ...

The evolution of biomedical science can be appreciated through studies of hemoglobin, the oxygen-carrying protein in red cells. Before molecular cloning, the geneticist Arno Motulsky noted, “Many ...

The optimal duration of adjuvant imatinib has yet to be determined, and clinical trials are ongoing to address this. KIT-directed tyrosine kinase inhibitors (TKIs) are the key treatment for advanced ...

The National Institute for Health and Care Excellence (NICE) has approved osimertinib (Tagrisso, AstraZeneca) for some lung cancer patients in England. In final draft guidance, the regulator decided ...

In this exclusive MedPage Today video, Virginia Kaklamani, MD, DSc, of UT Health Sciences Center in San Antonio and co-director of the San Antonio Breast Cancer Symposium (SABCS), discusses a subgroup ...

SHANGHAI, Nov. 20, 2024 /PRNewswire/ -- On November 20, 2024, the National Medical Products Administration (NMPA) announced on its official website that the NMPA approved the listing of Zorifertinib ...